--(BUSINESS WIRE)--The Myelin Repair Foundation:
“Accelerating New Treatments for Multiple Sclerosis and All Diseases”
WHAT: The Myelin Repair Foundation (www.myelinrepair.org) is presenting at the 2012 Partnering for Cures conference in New York City. CEO, President and Founder Scott Johnson from the Myelin Repair Foundation will be participating as a panelist at the “Powered by Patients” luncheon plenary session, along with leading healthcare innovators including Francis Collins, MD, PhD, Director of the National Institutes of Health and N. Anthony Coles, President, CEO, and Member of the Board at Onyx Pharmaceuticals. In addition, Scott Johnson will be presenting “Accelerating New Treatments for Multiple Sclerosis and All Diseases”, as one of 30 transformative, cross-sector collaborations featured in the Innovator Presentation track of the meeting. The Myelin Repair Foundation’s innovator presentation will discuss its Accelerated Research Collaboration™ (ARC™) model and Translational Medicine Platform which accelerates therapeutics development into effective patient treatments.
The Myelin Repair Foundation’s Accelerated Research Collaboration model is designed to optimize the entire therapeutics development continuum through collaboration, for multiple sclerosis and all diseases. As part of its ARC model, the Myelin Repair Foundation’s Translational Medicine Platform evaluates and identifies promising drug candidates for successful clinical trials. The Myelin Repair Foundation’s own Translational Medicine Center, a world-class laboratory that examines potential therapeutics for myelin repair, de-risks new disease approaches for the pharmaceutical industry and clears the pathway to clinical trials.
The Myelin Repair Foundation is focused on establishing a new collaborative paradigm for medical research, leveraging its position as a non-partisan entity to accelerate and develop new therapeutics to meet patient need.
WHO: CEO, President and Founder Scott Johnson from the Myelin Repair Foundation
WHEN: Partnering for Cures will be held November 28-30, 2012. The “Powered by Patients” luncheon plenary session is scheduled for Friday, November 30 at 1:00pm ET in the Empire Ballroom II-IV. The “Accelerating New Treatments for Multiple Sclerosis and All Diseases: The Myelin Repair Foundation” innovator presentation is scheduled for Friday, November 30 at 10:15am ET in the Uris/Juilliard room.
WHERE: Grand Hyatt Hotel, New York City
BACKGROUND: Partnering for Cures brings together 800 leaders from all sectors of the medical research enterprise to speed up the time it takes to turn promising scientific discoveries into treatments. It is convened by FasterCures, a center of the Milken Institute.
This year’s Partnering for Cures conference features a stellar speaker line-up, including: NIH's Francis Collins, FDA's Janet Woodcock, QB3's Regis Kelly, Arizona State University's Anna Barker, Onyx Pharmaceuticals’ Anthony Coles, PureTech Ventures’ Ben Shapiro, the Michael J. Fox Foundation’s Todd Sherer, and many other leaders from industry, academia, finance, philanthropy, and government. Partnering for Cures also features a state-of-the-art partnering system that eases the process of networking and finding nontraditional allies.
For more information and to register, please visit www.partneringforcures.org.
About the Myelin Repair Foundation
The Myelin Repair Foundation (MRF) (http://www.myelinrepair.org) is a Silicon Valley-based, non-profit research organization focused on accelerating the discovery and development of myelin repair therapeutics for multiple sclerosis. Its Accelerated Research Collaboration™ (ARC™) model is designed to optimize the entire process of medical research, drug development and the delivery of patient treatments.